TR200200738T2 - Therapeutic removal of endometrial tissue outside the uterus, chronic lower abdominal pain and fallopian tube obstruction. - Google Patents
Therapeutic removal of endometrial tissue outside the uterus, chronic lower abdominal pain and fallopian tube obstruction.Info
- Publication number
- TR200200738T2 TR200200738T2 TR2002/00738T TR200200738T TR200200738T2 TR 200200738 T2 TR200200738 T2 TR 200200738T2 TR 2002/00738 T TR2002/00738 T TR 2002/00738T TR 200200738 T TR200200738 T TR 200200738T TR 200200738 T2 TR200200738 T2 TR 200200738T2
- Authority
- TR
- Turkey
- Prior art keywords
- abdominal pain
- fallopian tube
- uterus
- lower abdominal
- endometrial tissue
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/06—Antiabortive agents; Labour repressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
- A61P5/04—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin for decreasing, blocking or antagonising the activity of the hypothalamic hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
- A61P5/08—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH for decreasing, blocking or antagonising the activity of the anterior pituitary hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/26—Androgens
Abstract
Mevcut bulus LHRH antagonistinin kisa süreli indükleme tedavisi ile yaklasik 4 ila 12 haftalik bir süre boyunca endometriyal dokunun rahim disi çogalmasi, kronik alt karin agrisi ve fallop tüpü tikanikliginin terapötik olarak giderilmesi için bir yöntem saglar.The present invention provides a method for therapeutic elimination of endometrial tissue prosthesis, chronic lower abdominal pain, and fallopian tube blockage for a period of approximately 4 to 12 weeks with short-term induction therapy of the LHRH antagonist.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US15547899P | 1999-09-23 | 1999-09-23 |
Publications (1)
Publication Number | Publication Date |
---|---|
TR200200738T2 true TR200200738T2 (en) | 2002-08-21 |
Family
ID=22555601
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TR2002/00738T TR200200738T2 (en) | 1999-09-23 | 2000-09-20 | Therapeutic removal of endometrial tissue outside the uterus, chronic lower abdominal pain and fallopian tube obstruction. |
Country Status (22)
Country | Link |
---|---|
EP (1) | EP1214086A2 (en) |
JP (2) | JP2003509467A (en) |
KR (1) | KR100772852B1 (en) |
CN (2) | CN1376070A (en) |
AU (1) | AU769482B2 (en) |
BG (1) | BG66128B1 (en) |
BR (1) | BR0014198A (en) |
CA (1) | CA2383510A1 (en) |
HK (1) | HK1049117A1 (en) |
HU (1) | HUP0202741A3 (en) |
IL (1) | IL148185A0 (en) |
MX (1) | MXPA02002436A (en) |
NO (1) | NO331198B1 (en) |
NZ (1) | NZ534836A (en) |
PL (1) | PL201898B1 (en) |
RU (1) | RU2255759C2 (en) |
SK (1) | SK3752002A3 (en) |
TR (1) | TR200200738T2 (en) |
TW (1) | TWI267373B (en) |
UA (1) | UA73956C2 (en) |
WO (1) | WO2001021194A2 (en) |
ZA (1) | ZA200201374B (en) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10157628A1 (en) * | 2001-11-26 | 2003-06-12 | Zentaris Ag | Solution for injection of an LHRH antagonist |
US7214662B2 (en) | 2001-11-27 | 2007-05-08 | Zentaris Gmbh | Injectable solution of an LHRH antagonist |
DK2252627T3 (en) | 2008-01-24 | 2017-08-14 | Esperance Pharmaceuticals | MERGER CONSTRUCTION WITH LYTIC DOMAIN AND METHOD FOR PRODUCING AND USING SAME. |
CA2750582A1 (en) * | 2009-01-22 | 2010-07-29 | Maatschap Interne Geneeskunde Rijnstate | Method for the prophylaxis or treatment of flushing |
CA2889475A1 (en) | 2012-10-30 | 2014-05-08 | Esperance Pharmaceuticals, Inc. | Antibody/drug conjugates and methods of use |
US10881659B2 (en) | 2013-03-15 | 2021-01-05 | Abbvie Inc. | Methods of treating heavy menstrual bleeding |
CA3097340A1 (en) | 2018-04-19 | 2019-10-24 | Abbvie Inc. | Methods of treating heavy menstrual bleeding |
EP3560555A1 (en) * | 2018-04-26 | 2019-10-30 | LifeArc | A composition for treating one or more estrogen related diseases |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5064939A (en) * | 1990-02-06 | 1991-11-12 | The Salk Institute For Biological Studies | Cyclic gnrh antagonists |
SE9301606D0 (en) * | 1993-05-07 | 1993-05-07 | Per-Christer Oden | COMPOSITION FOR THE TREATMENT OF IMPAIRED HAIR GROWTH |
US5658884A (en) * | 1994-07-22 | 1997-08-19 | The Medical College Of Hampton Roads | Establishment of tonic ovarian estrogen secretion for extended therapeutic regimens |
ES2145286T3 (en) * | 1994-07-22 | 2000-07-01 | Hampton Roads Medical College | USE OF A GNRH ANTAGONIST FOR THE PREPARATION OF A PHARMACEUTICAL COMPOSITION. |
DE19513662A1 (en) * | 1995-04-08 | 1996-10-10 | Schering Ag | Combined pharmaceutical preparation for hormonal contraception |
DE19604231A1 (en) * | 1996-01-29 | 1997-07-31 | Schering Ag | Combined pharmaceutical preparation and its use for the treatment of gynecological disorders |
WO1998009645A1 (en) * | 1996-09-04 | 1998-03-12 | Dott Research Laboratory | Peptide-containing drug compositions for oral administration |
WO1998055470A1 (en) * | 1997-06-05 | 1998-12-10 | Merck & Co., Inc. | Antagonists of gonadotropin releasing hormone |
DE19911771B4 (en) * | 1999-03-17 | 2006-03-30 | Zentaris Gmbh | LHRH antagonist, process for its preparation and its use |
-
2000
- 2000-09-20 RU RU2002111000/14A patent/RU2255759C2/en not_active IP Right Cessation
- 2000-09-20 IL IL14818500A patent/IL148185A0/en not_active IP Right Cessation
- 2000-09-20 CN CN00813196A patent/CN1376070A/en active Pending
- 2000-09-20 WO PCT/EP2000/009212 patent/WO2001021194A2/en active IP Right Grant
- 2000-09-20 TR TR2002/00738T patent/TR200200738T2/en unknown
- 2000-09-20 EP EP00967722A patent/EP1214086A2/en not_active Withdrawn
- 2000-09-20 AU AU77792/00A patent/AU769482B2/en not_active Ceased
- 2000-09-20 SK SK375-2002A patent/SK3752002A3/en not_active Application Discontinuation
- 2000-09-20 UA UA2002043346A patent/UA73956C2/en unknown
- 2000-09-20 CN CNA2007100789192A patent/CN101045155A/en active Pending
- 2000-09-20 JP JP2001524618A patent/JP2003509467A/en not_active Withdrawn
- 2000-09-20 MX MXPA02002436A patent/MXPA02002436A/en active IP Right Grant
- 2000-09-20 NZ NZ534836A patent/NZ534836A/en not_active IP Right Cessation
- 2000-09-20 PL PL353244A patent/PL201898B1/en not_active IP Right Cessation
- 2000-09-20 CA CA002383510A patent/CA2383510A1/en not_active Abandoned
- 2000-09-20 BR BR0014198-4A patent/BR0014198A/en not_active Application Discontinuation
- 2000-09-20 HU HU0202741A patent/HUP0202741A3/en unknown
- 2000-09-20 KR KR1020027003740A patent/KR100772852B1/en not_active IP Right Cessation
- 2000-09-22 TW TW089119671A patent/TWI267373B/en not_active IP Right Cessation
-
2002
- 2002-02-19 ZA ZA200201374A patent/ZA200201374B/en unknown
- 2002-03-21 NO NO20021430A patent/NO331198B1/en not_active IP Right Cessation
- 2002-04-05 BG BG106584A patent/BG66128B1/en unknown
-
2003
- 2003-02-18 HK HK03101215.4A patent/HK1049117A1/en unknown
-
2011
- 2011-10-17 JP JP2011227603A patent/JP2012051920A/en active Pending
Also Published As
Publication number | Publication date |
---|---|
CA2383510A1 (en) | 2001-03-29 |
WO2001021194A3 (en) | 2002-03-14 |
NO20021430L (en) | 2002-05-07 |
EP1214086A2 (en) | 2002-06-19 |
NZ534836A (en) | 2007-07-27 |
PL353244A1 (en) | 2003-11-03 |
AU7779200A (en) | 2001-04-24 |
JP2003509467A (en) | 2003-03-11 |
MXPA02002436A (en) | 2003-02-12 |
NO20021430D0 (en) | 2002-03-21 |
PL201898B1 (en) | 2009-05-29 |
RU2255759C2 (en) | 2005-07-10 |
BG106584A (en) | 2003-02-28 |
WO2001021194A2 (en) | 2001-03-29 |
KR100772852B1 (en) | 2007-11-02 |
HK1049117A1 (en) | 2003-05-02 |
AU769482B2 (en) | 2004-01-29 |
BR0014198A (en) | 2002-05-21 |
NO331198B1 (en) | 2011-10-31 |
IL148185A0 (en) | 2002-09-12 |
UA73956C2 (en) | 2005-10-17 |
CN1376070A (en) | 2002-10-23 |
CN101045155A (en) | 2007-10-03 |
BG66128B1 (en) | 2011-06-30 |
SK3752002A3 (en) | 2003-06-03 |
HUP0202741A2 (en) | 2003-01-28 |
HUP0202741A3 (en) | 2003-12-29 |
TWI267373B (en) | 2006-12-01 |
ZA200201374B (en) | 2002-10-30 |
JP2012051920A (en) | 2012-03-15 |
KR20020035879A (en) | 2002-05-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR0015284A (en) | Controlled Release Hydrocodone Formulations | |
GB0013674D0 (en) | Therapeutic use | |
HK1064921A1 (en) | Sustained release formulations of oxymorphone | |
DK0893998T4 (en) | Delivery of nicotine into the large intestine for the treatment of inflammatory bowel diseases | |
CY1106763T1 (en) | PREVENTIVE OR THERAPEUTIC MEANS FOR INFLAMMATORY BOWEL DISEASES | |
NZ517039A (en) | Intravaginal clindamycin ovule composition, where the clindamycin is dispersed in a hard fat suppository base | |
NO20014519L (en) | Apomorphine and Sildenafil Preparation | |
ES2164040T1 (en) | USE OF AGONISTS OF THE GLICINE UNION SITE OR INHIBITORS OF GLYCIN ABSORPTION FOR THE TREATMENT OF NEUROPSYCHIATRIC DISORDERS. | |
BR0010869A (en) | Method for administering a corticosteroid to a posterior segment of an eye and implantable sustained release device | |
ATE320796T1 (en) | PHARMACEUTICAL PREPARATION FOR THE TREATMENT OF ANAL INCONTINENCE AND ANAL ITCHING | |
SE0002754D0 (en) | New pharmaceutical combination formulation and method of treatment with the combination | |
MXPA05013927A (en) | Improved dispensing device. | |
TR200200738T2 (en) | Therapeutic removal of endometrial tissue outside the uterus, chronic lower abdominal pain and fallopian tube obstruction. | |
DK0998287T3 (en) | Use of levobupivacaine | |
EP1889614A3 (en) | Methods of using rapid-onset selective serotonin reuptake inhibitors for treating sexual dysfunction | |
ATE297732T1 (en) | COMBINATION THERAPY FOR THE TREATMENT OF HEART FAILURE | |
CA2416879A1 (en) | Methods of treating cancer and the pain associated therewith using endothelin antagonists | |
SE9904424D0 (en) | Use of interleukin-6 in combination with leptin in the treatment of obesity | |
EP1347754A4 (en) | Compositions for adhesion prevention | |
TR200100670T2 (en) | The use of R (+) - alpha- (2,3-Dimethoxyphenyl) -1- [2- (4-fluorophenyl) ethyl] -4-piperidinmethanol in the treatment of sleep disorders. | |
GR1003588B (en) | Wheelchair of multiple use |